These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 10630610)

  • 1. Disruption of operant oral self-administration of ethanol, sucrose, and saccharin by the AMPA/kainate antagonist, NBQX, but not the AMPA antagonist, GYKI 52466.
    Stephens DN; Brown G
    Alcohol Clin Exp Res; 1999 Dec; 23(12):1914-20. PubMed ID: 10630610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors.
    Mead AN; Stephens DN
    J Pharmacol Exp Ther; 1999 Jul; 290(1):9-15. PubMed ID: 10381753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
    Parsons CG; Gruner R; Rozental J
    Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
    Xue D; Huang ZG; Barnes K; Lesiuk HJ; Smith KE; Buchan AM
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):251-61. PubMed ID: 7509339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microdialysis of dopamine in the nucleus accumbens of alcohol-preferring (P) rats during anticipation and operant self-administration of ethanol.
    Melendez RI; Rodd-Henricks ZA; Engleman EA; Li TK; McBride WJ; Murphy JM
    Alcohol Clin Exp Res; 2002 Mar; 26(3):318-25. PubMed ID: 11923583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some central effects of GYKI 52466, a non-competitive AMPA receptor antagonist.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Pol J Pharmacol; 1995; 47(6):501-7. PubMed ID: 8868372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroprotective and hypothermic effect of GYKI-52466, a non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-antagonist on histological and behavioural variables in the gerbil global ischemia model.
    Gyertyán I; Gigler G; Simó A
    Brain Res Bull; 1999 Oct; 50(3):179-86. PubMed ID: 10566979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists.
    Maj J; Rogóz Z; Skuza G; Jaros T
    Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of GYKI 52466, a selective non-competitive antagonist of AMPA/kainate receptors, with conventional antiepileptic drugs in amygdala-kindled seizures in rats.
    Borowicz KK; Duda AM; Kleinrok Z; Czuczwar SJ
    Pol J Pharmacol; 2001; 53(2):101-8. PubMed ID: 11787948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of AMPA-type glutamate receptor antagonists on intermale social behavior in two mouse lines bidirectionally selected for offensive aggression.
    Vekovischeva OY; Aitta-aho T; Verbitskaya E; Sandnabba K; Korpi ER
    Pharmacol Biochem Behav; 2007; 87(2):241-9. PubMed ID: 17537494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking the trigeminal EPSP in rat abducens motoneurons in vivo with the AMPA antagonists NBQX and GYKI 53655.
    Ruiz A; Durand J
    Brain Res Bull; 2000 May; 52(2):99-107. PubMed ID: 10808079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
    Swedberg MD; Jacobsen P; Honoré T
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of repeated withdrawal from chronic ethanol on oral self-administration of ethanol on a progressive ratio schedule.
    Brown G; Jackson A; Stephens DN
    Behav Pharmacol; 1998 Mar; 9(2):149-61. PubMed ID: 10065934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration.
    Schroeder JP; Olive F; Koenig H; Hodge CW
    Alcohol Clin Exp Res; 2003 Dec; 27(12):1884-91. PubMed ID: 14691375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tiagabine and diazepam on operant ethanol self-administration in the rat.
    Rimondini R; Sommer W; Heilig M
    J Stud Alcohol; 2002 Jan; 63(1):100-6. PubMed ID: 11925051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide-Y Y5 receptors modulate the onset and maintenance of operant ethanol self-administration.
    Schroeder JP; Iller KA; Hodge CW
    Alcohol Clin Exp Res; 2003 Dec; 27(12):1912-20. PubMed ID: 14691378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive relationship between activity in a novel environment and operant ethanol self-administration in rats.
    Nadal R; Armario A; Janak PH
    Psychopharmacology (Berl); 2002 Jul; 162(3):333-8. PubMed ID: 12122492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Operant self-administration of sweetened versus unsweetened ethanol: effects on blood alcohol levels.
    Roberts AJ; Heyser CJ; Koob GF
    Alcohol Clin Exp Res; 1999 Jul; 23(7):1151-7. PubMed ID: 10443980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPA receptors and motivation for drug: effect of the selective antagonist NBQX on behavioural sensitization and on self-administration in mice.
    Jackson A; Mead AN; Rocha BA; Stephens DN
    Behav Pharmacol; 1998 Sep; 9(5-6):457-67. PubMed ID: 9832931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice.
    Czuczwar SJ; Borowicz KK; Kleinrok Z; Tutka P; Zarnowski T; Turski WA
    Eur J Pharmacol; 1995 Aug; 281(3):327-33. PubMed ID: 8521917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.